BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17270001)

  • 21. Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycin.
    Gu Q; Xia HH; Wang WH; Wang JD; Wong WM; Chan AO; Yuen MF; Lam SK; Cheung HK; Liu XG; Wong BC
    Aliment Pharmacol Ther; 2004 Sep; 20(6):675-81. PubMed ID: 15352916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori infection and the risk of gastric malignancy.
    Hsu PI; Lai KH; Hsu PN; Lo GH; Yu HC; Chen WC; Tsay FW; Lin HC; Tseng HH; Ger LP; Chen HC
    Am J Gastroenterol; 2007 Apr; 102(4):725-30. PubMed ID: 17324128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between Helicobacter pylori, inflammatory (neutrophil) activity, chronic gastritis, gastric atrophy and intestinal metaplasia.
    Tanko MN; Manasseh AN; Echejoh GO; Mandong BM; Malu AO; Okeke EN; Ladep N; Agaba EI
    Niger J Clin Pract; 2008 Sep; 11(3):270-4. PubMed ID: 19140368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking, Helicobacter pylori virulence, and type of intestinal metaplasia in Portuguese males.
    Peleteiro B; Lunet N; Figueiredo C; Carneiro F; David L; Barros H
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):322-6. PubMed ID: 17301266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer.
    Kim CG; Choi IJ; Lee JY; Cho SJ; Nam BH; Kook MC; Hong EK; Kim YW
    J Gastroenterol Hepatol; 2009 Mar; 24(3):469-74. PubMed ID: 19067779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of bile reflux and Helicobacter pylori infection on inflammation of gastric remnant after distal gastrectomy.
    Li XB; Lu H; Chen HM; Chen XY; Ge ZZ
    J Dig Dis; 2008 Nov; 9(4):208-12. PubMed ID: 18959592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients.
    Kindlund B; Sjöling A; Hansson M; Edebo A; Hansson LE; Sjövall H; Svennerholm AM; Lundin BS
    Helicobacter; 2009 Jun; 14(3):192-201. PubMed ID: 19702849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil.
    Motta CR; Cunha MP; Queiroz DM; Cruz FW; Guerra EJ; Mota RM; Braga LL
    Digestion; 2008; 78(1):3-8. PubMed ID: 18689994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.
    Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Ueki N; Shinji Y; Kusunoki M; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Digestion; 2006; 74(3-4):187-98. PubMed ID: 17341852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
    Kato S; Matsukura N; Matsuda N; Tsuchiya S; Naito Z; Tajiri T
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
    Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
    J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric atrophy and intestinal metaplasia changes 8 years after Helicobacter pylori eradication. A blind, randomised study.
    Rocco A; Suriani R; Cardesi E; Venturini I; Mazzucco D; Nardone G
    Minerva Gastroenterol Dietol; 2002 Jun; 48(2):175-8. PubMed ID: 16489312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: Helicobacter pylori eradication for the prevention of gastric cancer.
    De Vries AC; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():25-35. PubMed ID: 18081646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients.
    Leung WK; Ng EK; Chan WY; Auyeung AC; Chan KF; Lam CC; Chan FK; Lau JY; Sung JJ
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2982-6. PubMed ID: 16365021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Helicobacter pylori and prevention of gastric cancer.
    Cheung TK; Wong BC
    J Dig Dis; 2008 Feb; 9(1):8-13. PubMed ID: 18251788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type.
    Takenaka R; Okada H; Kato J; Makidono C; Hori S; Kawahara Y; Miyoshi M; Yumoto E; Imagawa A; Toyokawa T; Sakaguchi K; Shiratori Y
    Aliment Pharmacol Ther; 2007 Apr; 25(7):805-12. PubMed ID: 17373919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori infection and family history of gastric cancer decrease expression of FHIT tumor suppressor gene in gastric mucosa of dyspeptic patients.
    Stec-Michalska K; Peczek L; Michalski B; Wisniewska-Jarosinska M; Krakowiak A; Nawrot B
    Helicobacter; 2009 Oct; 14(5):126-34. PubMed ID: 19751438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
    Katsinelos P; Tziomalos K; Chatzimavroudis G; Vasiliadis T; Katsinelos T; Pilpilidis I; Triantafillidis I; Paroutoglou G; Papaziogas B
    Med Princ Pract; 2007; 16(2):119-23. PubMed ID: 17303947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.